SNDL Inc. SNDL

Healthcare SIC 2833 - Medicinal Chemicals & Botanical Products NAICS Manufacturing › Chemical Manufacturing › Pharmaceutical and Medicine Manufacturing › Medicinal and Botanical Manufacturing derived Nasdaq

Last close —

Market cap —

52-week range — - —

No price or market cap here: this company files no 10-K, so the only share count SEC publishes for it counts its ordinary shares in its home market, while its US listing is a depositary receipt standing for some number of them. That number is in no filing, so a price multiplied by that count is not this company's value and is not shown. The financial statements below are as filed.

Valuation FY2025 figures against the last close

P/S—

P/E—

P/FCF—

EV/EBITDA—

Dividend yield—

Diluted EPS—

Annual financial statements

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001193125-26-102524.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)

Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity

Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks

No annual figures to plot for this company yet.

Others in SIC 2833

Ticker	Company	Market cap	P/E	Revenue growth
DFTX	Definium Therapeutics, Inc.	$4.79B	—	—
TRLV	Trulieve Cannabis Corp.	$2.01B	—	-0.4%
CRON	Cronos Group Inc.	$1.23B	—	24.6%
TLRY	Tilray Brands, Inc.	$382.7M	—	11.5%
CGC	Canopy Growth Corp	$285.9M	—	—
USNA	USANA HEALTH SCIENCES INC	$257.9M	24.1x	8.3%
NAGE	Niagen Bioscience, Inc.	$192.3M	12.2x	29.9%
FTLF	FITLIFE BRANDS, INC.	$78.4M	13.3x	26.4%